Health

AG2R La Mondiale committed capital to lending platform Younited Credit. The larger round is not surprising as the alternative lending space is experiencing a recovery after the pandemic shock.

Munich Re and Microsoft helped CO2-to-chemicals technology provider Twelve raise $57m while Eli Lilly and Kaiser Permanente-backed CRO dMed-Clinipac secured $50m.

The precision oncology platform is based on research by Duke and Hubrecht Institute faculty and the cash will fund technology development and clinical studies.

The Alibaba-backed medical data software provider has reportedly halted plans for a $211m offering due to regulatory concerns.

The fund will invest in companies linked to École Polytechnique, including spinouts, alumni-founded startups or businesses incubated by the school.

Medison has contributed to a private placement in support of portfolio company Alpha Tau Medical’s $1bn reverse merger with Healthcare Capital Corp.

The Sanofi-backed vaccine developer has filed to float on the Nasdaq Global Select Market and set a placeholder target of $100m.

GV contributed to the precision oncology platform developer's series A round, which will fund technology development and clinical studies.

Novo and Sanofi Ventures both participated in a series A round for the neurodegenrative disease drug developer, which is led by EIRs at Novo Seeds.

The musculoskeletal healthcare provider has added cash from Intermountain Healthcare, Ascension Ventures and Echo Health Ventures to a round now surpassing $50m.

VIB and V-Bio Ventures have both participated in a series A round for Muna Therapeutics, the result of a merger of two recent spinouts.